Genomics analysis indicates that HG1 and HG3 breast carcinomas develop independently along different genetic pathways [10, 11], while HG2 patients (comprising ~ 50% of breast cancer cases) contain a blend of histological features, some of which are common to both HG1 and HG3 tumors, and exhibit a mixed gene expression profiles of HG1 and HG3 [12, 13]. Here, PKD1P3 is linked to breast carcinoma.